Entera Bio Ltd (ENTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Entera Bio Ltd-Aktie (ENTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	0.042	0.082	0.042
Cost Of Revenue	-	-	0.042	0.082	0.042
Gross Profit	-	-	-	-	-
Operating Expenses	22.04% 3.256	2.668	2.563	2.337	3.021
Benefits Costs and Expenses	-	-	-	2.426	3.063
Costs And Expenses	22.04% 3.256	2.668	2.605	2.426	3.063
Operating Income/Loss	22.04% -3.256	-2.668	-2.563	-2.337	-3.021
Nonoperating Income/Loss	366.67% 0.056	0.012	-0.004	-0.007	-
Income/Loss From Continuing Operations Before Tax	20.48% -3.20	-2.656	0.042	-2.344	-3.021
Income/Loss From Continuing Operations After Tax	20.48% -3.20	-2.656	-2.567	-2.358	-3.021
Net Income/Loss	20.48% -3.20	-2.656	-2.567	-2.358	-3.021
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.54% 47.09	46.84	43.38	0.4867	37.64
Diluted Average Shares	0.54% 47.09	46.84	43.38	0.4867	37.64
Basic Earnings Per Share	16.67% 0.07	0.06	0.06	0.06	0.08
Diluted Earnings Per Share	16.67% 0.07	0.06	0.06	0.06	0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%